Current Knowledge and Future Therapeutic Prospects in Symptomatic Intervertebral Disc Degeneration
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Joo Han | - |
dc.contributor.author | Ham, Chang Hwa | - |
dc.contributor.author | Kwon, Woo-Keun | - |
dc.date.accessioned | 2022-04-28T16:40:20Z | - |
dc.date.available | 2022-04-28T16:40:20Z | - |
dc.date.created | 2022-04-28 | - |
dc.date.issued | 2022-03 | - |
dc.identifier.issn | 0513-5796 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/140460 | - |
dc.description.abstract | Intervertebral disc (IVD) degeneration is the main source of intractable lower back pain, and symptomatic IVD degeneration could be due to different degeneration mechanisms. In this article, we describe the molecular basis of symptomatic IVD degenerative disc diseases (DDDs), emphasizing the role of degeneration, inflammation, angiogenesis, and extracellular matrix (ECM) regulation during this process. In symptomatic DDD, pro-inflammatory mediators modulate catabolic reactions, resulting in changes in ECM homeostasis and, finally, neural/vascular ingrowth-related chronic intractable discogenic pain. In ECM homeostasis, anabolic protein-regulating genes show reduced expression and changes in ECM production, while matrix metalloproteinase gene expression increases and results in aggressive ECM degradation. The resultant loss of normal IVD viscoelasticity and a concomitant change in ECM composition are key mechanisms in DDDs. During inflammation, a macrophage-related cascade is represented by the secretion of high levels of pro-inflammatory cytokines, which induce inflammation. Aberrant angiogenesis is considered a key initiative pathologic step in symptomatic DDD. In reflection of angiogenesis, vascular endothelial growth factor expression is regulated by hypoxia-inducible factor-1 in the hypoxic conditions of IVDs. Furthermore, IVD cells undergoing degeneration potentially enhance neovascularization by secreting large amounts of angiogenic cytokines, which penetrate the IVD from the outer annulus fibrosus, extending deep into the outer part of the nucleus pulposus. Based on current knowledge, a multi-disciplinary approach is needed in all aspects of spinal research, starting from basic research to clinical applications, as this will provide information regarding treatments for DDDs and discogenic pain. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | YONSEI UNIV COLL MEDICINE | - |
dc.subject | LOW-BACK-PAIN | - |
dc.subject | NERVE GROWTH-FACTOR | - |
dc.subject | ANNULUS FIBROSUS CELLS | - |
dc.subject | NUCLEUS PULPOSUS CELLS | - |
dc.subject | OSTEOGENIC PROTEIN-1 INJECTION | - |
dc.subject | RABBIT NOTOCHORDAL CELLS | - |
dc.subject | NECROSIS-FACTOR-ALPHA | - |
dc.subject | INFLAMMATORY MEDIATORS | - |
dc.subject | EXTRACELLULAR-MATRIX | - |
dc.subject | SUBSTANCE-P | - |
dc.title | Current Knowledge and Future Therapeutic Prospects in Symptomatic Intervertebral Disc Degeneration | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Joo Han | - |
dc.identifier.doi | 10.3349/ymj.2022.63.3.199 | - |
dc.identifier.scopusid | 2-s2.0-85125020576 | - |
dc.identifier.wosid | 000758190500001 | - |
dc.identifier.bibliographicCitation | YONSEI MEDICAL JOURNAL, v.63, no.3, pp.199 - 210 | - |
dc.relation.isPartOf | YONSEI MEDICAL JOURNAL | - |
dc.citation.title | YONSEI MEDICAL JOURNAL | - |
dc.citation.volume | 63 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 199 | - |
dc.citation.endPage | 210 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002810850 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | LOW-BACK-PAIN | - |
dc.subject.keywordPlus | NERVE GROWTH-FACTOR | - |
dc.subject.keywordPlus | ANNULUS FIBROSUS CELLS | - |
dc.subject.keywordPlus | NUCLEUS PULPOSUS CELLS | - |
dc.subject.keywordPlus | OSTEOGENIC PROTEIN-1 INJECTION | - |
dc.subject.keywordPlus | RABBIT NOTOCHORDAL CELLS | - |
dc.subject.keywordPlus | NECROSIS-FACTOR-ALPHA | - |
dc.subject.keywordPlus | INFLAMMATORY MEDIATORS | - |
dc.subject.keywordPlus | EXTRACELLULAR-MATRIX | - |
dc.subject.keywordPlus | SUBSTANCE-P | - |
dc.subject.keywordAuthor | Symptomatic intervertebral disc degeneration | - |
dc.subject.keywordAuthor | pro-inflammatory cytokines | - |
dc.subject.keywordAuthor | angiogenesis | - |
dc.subject.keywordAuthor | nerve ingrowth | - |
dc.subject.keywordAuthor | treatment | - |
dc.subject.keywordAuthor | of DDD | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.